Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Trial Profile

Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Becaplermin (Primary)
  • Indications Diabetic foot ulcer; Leg ulcer
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
    • 28 Aug 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Sep 2020.
    • 28 Aug 2017 Planned initiation date changed from 1 Oct 2016 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top